BGOG-ov-6

trinova-2

A Phase 3, Randomized, Double-Blind Trial of Pegylated Liposomal Doxorubicin (PLD) Plus AMG 386 or Placebo in Women With Recurrent Partially Platinum Sensitive or Resistant Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer.
Protocol Number Amgen 20060517/ENGOT-ov-6
EudraCT Number 2009-017946-30

 

Study sites

  • AZ Sint-Lucas, Gent
  • CHA de l’Ardenne, Libramont
  • CHR Citadelle, Liège
  • Clinique et maternité St Elisabeth, Namur
  • Grand Hôpital de Charleroi, Charleroi
  • Jan Yperman Ziekenhuis,Ieper
  • UZ Antwerpen, Edegem
  • UZ Leuven, Leuven
 

Professional Area

Unlock